GSA Capital Partners’s Precision BioSciences DTIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-10,067
| Closed | -$137K | – | 1719 |
|
|
2024
Q1 | $137K | Buy |
+10,067
| New | +$137K | 0.01% | 1462 |
|
|
2023
Q3 | – | Sell |
-15,666
| Closed | -$247K | – | 1589 |
|
|
2023
Q2 | $247K | Sell |
15,666
-767
| -5% | -$12.1K | 0.02% | 1153 |
|
|
2023
Q1 | $372K | Buy |
16,433
+7,042
| +75% | +$159K | 0.04% | 896 |
|
|
2022
Q4 | $335K | Sell |
9,391
-1,075
| -10% | -$38.3K | 0.04% | 862 |
|
|
2022
Q3 | $408K | Buy |
10,466
+5,726
| +121% | +$223K | 0.05% | 724 |
|
|
2022
Q2 | $227K | Buy |
4,740
+987
| +26% | +$47.3K | 0.03% | 1007 |
|
|
2022
Q1 | $347K | Buy |
3,753
+2,038
| +119% | +$188K | 0.05% | 794 |
|
|
2021
Q4 | $381K | Sell |
1,715
-133
| -7% | -$29.5K | 0.05% | 772 |
|
|
2021
Q3 | $640K | Buy |
+1,848
| New | +$640K | 0.07% | 543 |
|
|
2020
Q4 | – | Sell |
-4,954
| Closed | -$916K | – | 1287 |
|
|
2020
Q3 | $916K | Buy |
4,954
+4,284
| +639% | +$792K | 0.15% | 121 |
|
|
2020
Q2 | $168K | Buy |
+670
| New | +$168K | 0.09% | 389 |
|